Juergen Lasowski Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Juergen Lasowski.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Juergen Lasowski. Juergen Lasowski is EVP, Corporate Development in ONYX PHARMACEUTICALS INC ($ONXX).
Latest Insider Trading Transactions of Juergen Lasowski
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 27 2012 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corporate Deve ... | Sell | S | 73.97 | 5,348 | 395,601 | 48,968 | 54.3 K to 49 K (-9.85 %) |
Jul 05 2012 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corporate Deve ... | Option Exercise | M | 28.55 | 14,000 | 399,700 | 25,375 | |
Jul 05 2012 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corporate Deve ... | Sell | D | 67.73 | 1,300 | 88,049 | 54,316 | 55.6 K to 54.3 K (-2.34 %) |
Jul 05 2012 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corporate Deve ... | Sell | D | 66.62 | 2,326 | 154,958 | 55,616 | 57.9 K to 55.6 K (-4.01 %) |
Jul 05 2012 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corporate Deve ... | Sell | D | 67.24 | 14,000 | 941,360 | 57,942 | 71.9 K to 57.9 K (-19.46 %) |
Jul 05 2012 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corporate Deve ... | Buy | M | 28.55 | 14,000 | 399,700 | 71,942 | 57.9 K to 71.9 K (+24.16 %) |
Apr 03 2012 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corporate Deve ... | Option Exercise | A | 37.68 | 45,900 | 1,729,512 | 45,900 | |
Apr 03 2012 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corporate Deve ... | Sell | D | 36.58 | 757 | 27,689 | 57,942 | 58.7 K to 57.9 K (-1.29 %) |
Apr 03 2012 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corporate Deve ... | Sell | D | 36.58 | 694 | 25,384 | 58,699 | 59.4 K to 58.7 K (-1.17 %) |
Apr 03 2012 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corporate Deve ... | Sell | D | 36.58 | 757 | 27,688 | 59,393 | 60.2 K to 59.4 K (-1.26 %) |
Apr 03 2012 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corporate Deve ... | Grant | A | 0.00 | 17,150 | 0 | 60,150 | 43 K to 60.2 K (+39.88 %) |
Apr 03 2012 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corporate Deve ... | Grant | A | 0.00 | 9,000 | 0 | 43,000 | 34 K to 43 K (+26.47 %) |
Jan 05 2012 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corporate Deve ... | Sell | S | 42.64 | 1,232 | 52,532 | 34,000 | 35.2 K to 34 K (-3.50 %) |
Sep 02 2011 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corporate Deve ... | Sell | S | 34.14 | 1,006 | 34,345 | 35,232 | 36.2 K to 35.2 K (-2.78 %) |
Aug 01 2011 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corporate Deve ... | Sell | S | 33.27 | 1,665 | 55,395 | 36,238 | 37.9 K to 36.2 K (-4.39 %) |
May 23 2011 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corporate Deve ... | Sell | S | 43.53 | 3 | 131 | 37,238 | 37.2 K to 37.2 K (-0.01 %) |
May 23 2011 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corporate Deve ... | Sell | S | 43.02 | 591 | 25,425 | 37,241 | 37.8 K to 37.2 K (-1.56 %) |
May 10 2011 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corporate Deve ... | Sell | S | 40.00 | 3,783 | 151,320 | 37,832 | 41.6 K to 37.8 K (-9.09 %) |
Apr 04 2011 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corporate Deve ... | Option Exercise | A | 35.18 | 40,000 | 1,407,200 | 40,000 | |
Apr 04 2011 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corporate Deve ... | Option Exercise | A | 35.18 | 38,500 | 1,354,430 | 38,500 | |
Apr 04 2011 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corporate Deve ... | Sell | S | 35.02 | 1,478 | 51,760 | 41,615 | 43.1 K to 41.6 K (-3.43 %) |
Apr 04 2011 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corporate Deve ... | Grant | A | 0.00 | 22,500 | 0 | 43,093 | 20.6 K to 43.1 K (+109.26 %) |
Apr 04 2011 | ONXX | ONYX PHARMACEUTICA ... | Lasowski Juergen | EVP, Corporate Deve ... | Grant | A | 0.00 | 5,500 | 0 | 20,593 | 15.1 K to 20.6 K (+36.44 %) |
Page: 1